Results 41 to 50 of about 6,107 (224)

The haemodynamic effects of the perioperative terlipressin infusion in living donor liver transplantation: A randomised controlled study

Indian Journal of Anaesthesia, 2015
Background and Aims: Liver disease is usually accompanied with a decline in systemic vascular resistance (SVR). We decided to assess effects of the peri-operative terlipressin infusion on liver donor liver transplantation recipients with respect to ...
Nagwa Ibrahim, Ashraf Hasanin, Sabry Abd Allah, Eman Sayed, Mohamed Afifi, Khaled Yassen, Wesam Saber, Magdy Khalil   +7 more
doaj   +1 more source

Terlipressin Induced Severe Hyponatremia

Prague Medical Report, 2016
Terlipressin is a vasopressin analogue used for its vasoconstrictor effect in the treatment of variceal bleeding. Despite its good safety profile compared to vasopressin, some adverse reactions may occur during its use – e.g. hyponatremia.
Martin Šíma, Miroslav Pokorný, František Paďour, Ondřej Slanař   +3 more
doaj   +1 more source

Two-component vasopressor therapy for septic shock

Вестник анестезиологии и реаниматологии, 2021
The objective: to investigate the efficacy and safety of terlipressin when it is used as an additional vasopressor in septic shock.Subjects: A single-center, observational, retrospective-prospective study of the efficacy and safety of combined therapy of
A. A. Kochkin, V. V. Likhvantsev, К. К. Kadantseva   +2 more
doaj   +1 more source

Is there any role for terlipressin in the extremely low birth weight infant with refractory septic shock?

Journal of Pediatric and Neonatal Individualized Medicine, 2012
Terlipressin, a synthetic long-acting analogue of vasopressin, has been investigated as a second line vasopressor in adults and children with refractory septic shock, i.e.
Francesca Bissolo, Carlo Alberto Forcellini, Stefania Spaggiari, Marcella Gaffuri, Giuseppe Pagano, Paolo Biban   +5 more
doaj   +1 more source

Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies

Gastro Hep Advances, 2023
Background and Aims: Type 1 hepatorenal syndrome (HRS) is a rapid deterioration in kidney function in patients with cirrhosis. Data on efficacy of vasoconstrictors for type 1 HRS have shown mixed results.
Ashwani K. Singal, Geralyn Palmer, Lauren Melick, Mohamed Abdallah, Paul Kwo   +4 more
doaj   +1 more source

Continuous terlipressin infusion is associated with improved diet intake and muscle strength in patients awaiting liver transplant

JHEP Reports, 2019
Background & Aims: Portal hypertension contributes to the pathogenesis of malnutrition and sarcopenia in cirrhosis via multiple mechanisms. Terlipressin is a vasopressin analogue that we administer via continuous outpatient infusion, as a bridge to ...
Brooke Chapman, Paul Gow, Marie Sinclair, Timothy Hanrahan, Peter Angus, Tess McClure, Chris Mills, Ryma Terbah, Adam Testro   +8 more
doaj   +1 more source

Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies

Hepatology Communications, 2023
Hepatorenal syndrome type 1 (HRS-1) is a serious complication of advanced cirrhosis and a potentially reversible form of acute kidney injury that is associated with rapidly deteriorating kidney function.
M. Curry, H. Vargas, A. Befeler, N. Pyrsopoulos, V. Patwardhan, K. Jamil   +5 more
semanticscholar   +1 more source

Antiparallel β‐Sheet as a Key Motif of Amyloid‐β Inhibitor Designed via Topological Peptide Reprogramming

Angewandte Chemie, Volume 137, Issue 28, July 7, 2025.
Targeting Amyloid‐β (Aβ) aggregation requires a peptide‐based approach that accounts for the structural heterogeneity of Aβ. Here, we employ topological reprogramming via disulfide bonds to stabilize antiparallel β‐sheets within the dimeric peptide.
Dongjoon Im, Ye Eun Lee, Gyusub Yoon, William A. Goddard III, Tae Su Choi, Hugh I. Kim   +5 more
wiley   +2 more sources

Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial

BMC Anesthesiology, 2019
Background Terlipressin, in general, is a vasopressor which acts via V1 receptors. Its infusion elevates mean blood pressure and can reduce bleeding which has a splanchnic origin.
Magdy Mohammed Mahdy, Mostafa Samy Abbas, Emad Zarief Kamel, Mohamed Fathy Mostafa, Ragaa Herdan, Shimaa Abbas Hassan, Ramy Hassan, Ahmed M. Taha, Tameem M. Ibraheem, Bashir A. Fadel, Mohammed Geddawy, Jehan Ahmed Sayed, Osama Ali Ibraheim   +12 more
doaj   +1 more source

Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats

Scientific Reports, 2022
Hemorrhagic shock (HS), a major cause of trauma-related mortality, is mainly treated by crystalloid fluid administration, typically with lactated Ringer’s (LR).
Leticia Urbano Cardoso Castro, Denise Aya Otsuki, Talita Rojas Sanches, Felipe Lima Souza, Mirela Aparecida Rodrigues Santinho, Cleonice da Silva, Irene de Lourdes Noronha, Amaro Nunes Duarte-Neto, Samirah Abreu Gomes, Luiz-Marcelo Sá Malbouisson, Lucia Andrade   +10 more
doaj   +1 more source